HASAN ASIF: Open Payments
NPI 1710034160 · BRONXVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 64 payments from 9 companies in 2025. Trend: 2023 $1,213 · 2024 $2,119 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $206 |
| ABBVIE INC. | 17 | $203 |
| Alkermes, Inc. | 6 | $154 |
| Lundbeck LLC | 9 | $149 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| Bausch Health US, LLC | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
Products named: REXULTI, Auvelity, CAPLYTA, VRAYLAR, LYBALVI, INGREZZA, WELLBUTRIN, FANAPT.
Industry payments across NY — which companies pay providers there.
